Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

446

HTML

3348

Figures (1-5)

287

Tables (1-5)

283

Sum=4364

Jan 1, 2004 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jan 1, 2004; 10(1): 136-142
Published online Jan 1, 2004. doi: 10.3748/wjg.v10.i1.136

Table 5 Comparison in TIL responses by TNM stages between control and treatment groups

^aP < 0.05,

^bP < 0.01, vs control (Fisher’s exact test).

Citation: Lin CY, Bai DJ, Yuan HY, Wang K, Yang GL, Hu MB, Wu ZQ, Li Y. Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial. World J Gastroenterol 2004; 10(1): 136-142
URL: https://www.wjgnet.com/1007-9327/full/v10/i1/136.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i1.136